The product is an additional formulation of Cresemba Capsule 100 mg and Cresemba Intravenous Infusion 200 mg
The sale/transfer of the Company's API NonAntibiotic Business and API Antibiotic Business to Apitoria are complete
The market capitalization of the company stood at Rs. 7,000 crore +
Sets price band at ?695 to ?735 per Equity Share
Jupiter has filed its draft herring prospectus (DRHP) with the market regulator in May this year, to float its IPO
Oteseconazole Capsules were found to be safe and more effective than fluconazole
Zydus' Indomethacin suppositories also been granted 180-day CGT exclusivity to market this product.
The Long-term Safety Trial was approved to be conducted by China National Medical Products Administration (NMPA) on 18 April 2023
The company has submitted marketing authorization applications for mRNA-1345 with the European Medicines Agency (EMA), Swissmedic in Switzerland, and the Therapeutic Goods Administration (TGA) in Australia
Ensitrelvir is an oral antiviral that suppresses the replication of SARS-CoV-2 by selectively inhibiting the viral 3CL protease.
Subscribe To Our Newsletter & Stay Updated
